Lentivirus Platform: Optimizing Performance For De-Risked Production

A de-risked, reproducible, and scalable platform for efficient GMP manufacturing of lentiviral vectors is offered as part of MilliporeSigma's comprehensive viral vector development and manufacturing services.
The VirusExpress® lentivirus platform is a leading solution for suspension-based manufacturing. Its workflow is designed to optimize and de-risk lentivirus production, meeting the needs of cell and gene therapy innovators. This comprehensive platform delivers economical value, high quality, and performance with its industry-leading titer, robust recovery, streamlined and scalable workflow, comprehensive analytics, and reduced development timelines of less than 12 months.
Continue reading to learn how this platform maximizes lentiviral vector titers through upstream optimization and enriches lentiviral vector recovery through downstream optimization.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.